MARK A. BLINN - 04 Feb 2022 Form 4 Insider Report for TEXAS INSTRUMENTS INC (TXN)

Role
Director
Signature
/s/ Katharine Kane, Attorney In Fact
Issuer symbol
TXN
Transactions as of
04 Feb 2022
Net transactions value
-$333,792
Form type
4
Filing time
08 Feb 2022, 16:54:43 UTC
Previous filing
03 Feb 2022
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXN Common Stock Options Exercise $118,632 +1,077 +8.2% $110.15 14,140 04 Feb 2022 Direct
transaction TXN Common Stock Options Exercise $118,297 +1,133 +8% $104.41 15,273 04 Feb 2022 Direct
transaction TXN Common Stock Options Exercise $127,649 +978 +6.4% $130.52 16,251 04 Feb 2022 Direct
transaction TXN Common Stock Sale $78,028 -464 -2.9% $168.16 15,787 04 Feb 2022 Direct F1
transaction TXN Common Stock Sale $142,963 -845 -5.4% $169.19 14,942 04 Feb 2022 Direct F2
transaction TXN Common Stock Sale $108,230 -635 -4.2% $170.44 14,307 04 Feb 2022 Direct F3
transaction TXN Common Stock Sale $282,814 -1,650 -12% $171.40 12,657 04 Feb 2022 Direct F4
transaction TXN Common Stock Sale $86,334 -501 -4% $172.32 12,156 04 Feb 2022 Direct F5
holding TXN Common Stock 5,400 04 Feb 2022 By Trust F6
holding TXN Common Stock 5,400 04 Feb 2022 By Trust F7
holding TXN Common Stock 3,046 04 Feb 2022 By Trust F8
holding TXN Common Stock 1,200 04 Feb 2022 By Trust F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -1,077 -100% $0.000000* 0 04 Feb 2022 Common Stock 1,077 $110.15 Direct F10
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -1,133 -50% $0.000000 1,133 04 Feb 2022 Common Stock 1,133 $104.41 Direct F11
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -978 -33% $0.000000 1,956 04 Feb 2022 Common Stock 978 $130.52 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $167.65 to $168.48. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $168.775 to $169.69. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F3 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $169.985 to $170.915. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F4 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $171.01 to $171.89. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F5 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $172.055 to $172.68. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F6 Shares held in Trust for the benefit of family member of which reporting person is trustee. Beneficial ownership by reporting person disclaimed.
F7 Shares held in Trust for the benefit of the reporting person. Reporting person is the sole trustee.
F8 Shares held in Trust for the benefit of family member; reporting person shares investment control. Beneficial ownership by reporting person disclaimed.
F9 Shares held in Trust for the benefit of family member of which reporting person is a co-trustee. Beneficial ownership by reporting person disclaimed.
F10 The option became exercisable in four equal annual installments beginning on January 25, 2019.
F11 The option became exercisable in four equal annual installments beginning on January 25, 2020.
F12 The option became exercisable in four equal annual installments beginning on January 24, 2021.